About Cytochrome P450 4F12
Cytochrome P450 4F12 (CYP4F12) is a protein
from Homo sapiens identified by UniProt accession
Q9HCS2, 524 residues long.
MolForge cross-references it against 0 known binders and
243 disease associations.
Target properties
| Protein name | Cytochrome P450 4F12 |
| UniProt accession | Q9HCS2 |
| Gene | CYP4F12 |
| Organism | Homo sapiens |
| Length | 524 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (243)
Diseases linked to this target (Open Targets).
- low density lipoprotein cholesterol measurement · score 0.39
- total cholesterol measurement · score 0.34
- cutaneous melanoma · score 0.23
- glioblastoma multiforme · score 0.23
- lung adenocarcinoma · score 0.19
- endometrial cancer · score 0.16
- glioma · score 0.15
- urinary bladder cancer · score 0.11
- head and neck squamous cell carcinoma · score 0.11
- retinitis pigmentosa · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9HCS2-F1 | alphafold | PREDICTED | 90.77 | — |
Amino-acid sequence (524 residues)
MSLLSLPWLG LRPVATSPWL LLLLVVGSWL LARILAWTYA FYNNCRRLQC FPQPPKRNWF WGHLGLITPT EEGLKNSTQM SATYSQGFTV WLGPIIPFIV LCHPDTIRSI TNASAAIAPK DNLFIRFLKP WLGEGILLSG GDKWSRHRRM LTPAFHFNIL KSYITIFNKS ANIMLDKWQH LASEGSSRLD MFEHISLMTL DSLQKCIFSF DSHCQERPSE YIATILELSA LVEKRSQHIL QHMDFLYYLS HDGRRFHRAC RLVHDFTDAV IRERRRTLPT QGIDDFFKDK AKSKTLDFID VLLLSKDEDG KALSDEDIRA EADTFMFGGH DTTASGLSWV LYNLARHPEY QERCRQEVQE LLKDRDPKEI EWDDLAQLPF LTMCVKESLR LHPPAPFISR CCTQDIVLPD GRVIPKGITC LIDIIGVHHN PTVWPDPEVY DPFRFDPENS KGRSPLAFIP FSAGPRNCIG QAFAMAEMKV VLALMLLHFR FLPDHTEPRR KLELIMRAEG GLWLRVEPLN VSLQ
Explore Cytochrome P450 4F12 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets